SARS-CoV-2广

Siling Wang1,2, Hui Sun1,2, Yizhen Wang1,2

  • 1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China.

概括

具有单体尖端蛋白的双相对应的SARS-CoV-2疫苗产生广泛的中和抗体 (bnAbs) 对抗各种变体,包括像JN.1这样的Omicron亚型. 这项研究揭示了广泛保护的关键免疫机制,为通用疫苗设计提供了信息.